Detalles de la búsqueda
1.
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
Cancer
; 130(13): 2351-2360, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400828
2.
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.
Pediatr Radiol
; 53(12): 2539-2551, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37682330
3.
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
Pediatr Blood Cancer
; 69(9): e29739, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460336
4.
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
Pediatr Blood Cancer
; 68(3): e28832, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245207
5.
Combined resistance and aerobic exercise intervention improves fitness, insulin resistance and quality of life in survivors of childhood haemopoietic stem cell transplantation with total body irradiation.
Pediatr Blood Cancer
; 67(12): e28687, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044779
6.
Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).
Pediatr Blood Cancer
; 67(9): e28479, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573979
7.
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(11): 1566-1575, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562043
8.
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
Lancet Oncol
; 19(8): 1061-1071, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941280
9.
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Cancer
; 124(15): 3201-3209, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797665
10.
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
Cancer
; 124(5): 1016-1024, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29211298
11.
Respiratory mortality of childhood, adolescent and young adult cancer survivors.
Thorax
; 73(10): 959-968, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748251
12.
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
Pediatr Blood Cancer
; 65(9): e27096, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29781567
13.
Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28205365
14.
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.
Pediatr Blood Cancer
; 64(6)2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27882658
15.
A new standard of care for patients with high-risk rhabdomyosarcoma? - Authors' reply.
Lancet Oncol
; 21(1): e3, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31908304
16.
Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Pediatr Blood Cancer
; 61(2): 217-22, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23997024
17.
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Cancers (Basel)
; 16(5)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473359
18.
Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma.
Cancers (Basel)
; 15(2)2023 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672371
19.
Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials.
Radiother Oncol
; 182: 109549, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828140
20.
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.
Cancers (Basel)
; 15(15)2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568826